Hence, in NASH, DCs can limit CD8+ T cell expansion and restrict Toll-like receptor expression and cytokine production in innate immune effector cells, including KCs, neutrophils, and inflammatory monocytes127. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.